BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lugli A, Zlobec I, Berger MD, Kirsch R, Nagtegaal ID. Tumour budding in solid cancers. Nat Rev Clin Oncol 2021;18:101-15. [PMID: 32901132 DOI: 10.1038/s41571-020-0422-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Gijsbers KM, van der Schee L, van Veen T, van Berkel AM, Boersma F, Bronkhorst CM, Didden PD, Haasnoot KJ, Jonker AM, Kessels K, Knijn N, van Lijnschoten I, Mijnals C, Milne AN, Moll FC, Schrauwen RW, Schreuder R, Seerden TJ, Spanier MB, Terhaar Sive Droste JS, Witteveen E, de Vos tot Nederveen Cappel WH, Vleggaar FP, Laclé MM, ter Borg F, Moons LM; Dutch T1 CRC Working Group. Impact of ≥ 0.1-mm free resection margins on local intramural residual cancer after local excision of T1 colorectal cancer. Endosc Int Open 2022;10:E282-90. [DOI: 10.1055/a-1736-6960] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen K, Collins G, Wang H, Toh JWT. Pathological Features and Prognostication in Colorectal Cancer. Curr Oncol 2021;28:5356-83. [PMID: 34940086 DOI: 10.3390/curroncol28060447] [Reference Citation Analysis]
3 Jesinghaus M, Schmitt M, Lang C, Reiser M, Scheiter A, Konukiewitz B, Steiger K, Silva M, Tschurtschenthaler M, Lange S, Foersch S, Becker KF, Saur D, Friess H, Halfter K, Engel J, Boxberg M, Pfarr N, Wilhelm D, Weichert W. Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases. Am J Surg Pathol 2021;45:969-78. [PMID: 34105518 DOI: 10.1097/PAS.0000000000001692] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Okcu O, Öztürk Ç, Şen B, Arpa M, Bedir R. Tumor Budding is a reliable predictor for death and metastasis in invasive ductal breast cancer and correlates with other prognostic clinicopathological parameters. Ann Diagn Pathol 2021;54:151792. [PMID: 34293708 DOI: 10.1016/j.anndiagpath.2021.151792] [Reference Citation Analysis]
5 Roya P, Zameer L, Dey D, Datta J, Bardia A, Mishra D. Pathologist's perspectives on reporting of tumour budding in colorectal cancer. Ecancermedicalscience 2021;15:1337. [PMID: 35211206 DOI: 10.3332/ecancer.2021.1337] [Reference Citation Analysis]
6 Gurzu S, Jung I. Subcellular Expression of Maspin in Colorectal Cancer: Friend or Foe. Cancers (Basel) 2021;13:366. [PMID: 33498377 DOI: 10.3390/cancers13030366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Fisher NC, Loughrey MB, Coleman HG, Gelbard MD, Bankhead P, Dunne PD. Development of a semi-automated method for tumour budding assessment in colorectal cancer and comparison with manual methods. Histopathology 2021. [PMID: 34580909 DOI: 10.1111/his.14574] [Reference Citation Analysis]
8 Wu F, Shao R, Zheng P, Zhang T, Qiu C, Sui H, Li S, Jin L, Pan H, Jin X, Zou P, Cui R, Xie C. Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage. Front Oncol 2022;12:813854. [DOI: 10.3389/fonc.2022.813854] [Reference Citation Analysis]
9 Palamaris K, Felekouras E, Sakellariou S. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance. Cancers (Basel) 2021;13:5532. [PMID: 34771695 DOI: 10.3390/cancers13215532] [Reference Citation Analysis]
10 Grosser B, Glückstein MI, Dhillon C, Schiele S, Dintner S, VanSchoiack A, Kroeppler D, Martin B, Probst A, Vlasenko D, Schenkirsch G, Märkl B. Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes. J Pathol 2021. [PMID: 34580877 DOI: 10.1002/path.5810] [Reference Citation Analysis]
11 Hatthakarnkul P, Quinn JA, Matly AAM, Ammar A, van Wyk HC, McMillan DC, Edwards J. Systematic review of tumour budding and association with common mutations in patients with colorectal cancer. Crit Rev Oncol Hematol 2021;167:103490. [PMID: 34619332 DOI: 10.1016/j.critrevonc.2021.103490] [Reference Citation Analysis]
12 El Agy F, Bardai SE, Bouguenouch L, Lahmidani N, El Abkari M, Benjelloun EB, Ousadden A, Mazaz K, Imanetoughrai, Ibrahimi SA, Benbrahim Z, Chbani L, Gallo G. Prognostic Impact of Tumor Budding on Moroccan Colon Cancer Patients. International Journal of Surgical Oncology 2022;2022:1-10. [DOI: 10.1155/2022/9334570] [Reference Citation Analysis]
13 Gallo G. The Emerging Role of Tumor Deposits as an Independent Prognostic Factor in Advanced Colorectal Cancer. J Invest Surg 2021;:1-2. [PMID: 34130580 DOI: 10.1080/08941939.2021.1936304] [Reference Citation Analysis]
14 Regmi P, Paudyal A, Paudyal P, Hu HJ, Liu F, Ma WJ, Jin YW, Li FY. Prognostic significance of tumor budding in biliary tract cancer. Eur J Surg Oncol 2021:S0748-7983(21)00678-8. [PMID: 34412954 DOI: 10.1016/j.ejso.2021.08.008] [Reference Citation Analysis]
15 Seker NS, Tekin E, Özen A, Can C, Colak E, Acikalin MF. Prognostic significance of tumor budding in muscle invasive urothelial carcinomas of the urinary bladder. Ann Diagn Pathol 2021;54:151786. [PMID: 34229152 DOI: 10.1016/j.anndiagpath.2021.151786] [Reference Citation Analysis]
16 Hyun J, Kim HW. Leveraging cellular mechano-responsiveness for cancer therapy. Trends Mol Med 2021:S1471-4914(21)00317-8. [PMID: 34973934 DOI: 10.1016/j.molmed.2021.11.006] [Reference Citation Analysis]
17 Martin B, Grosser B, Kempkens L, Miller S, Bauer S, Dhillon C, Banner BM, Brendel EM, Sipos É, Vlasenko D, Schenkirsch G, Schiele S, Müller G, Märkl B. Stroma AReactive Invasion Front Areas (SARIFA)-A New Easily to Determine Biomarker in Colon Cancer-Results of a Retrospective Study. Cancers (Basel) 2021;13:4880. [PMID: 34638364 DOI: 10.3390/cancers13194880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Aust G, Zheng L, Quaas M. To Detach, Migrate, Adhere, and Metastasize: CD97/ADGRE5 in Cancer. Cells 2022;11:1538. [DOI: 10.3390/cells11091538] [Reference Citation Analysis]
19 Jiang H, Yang Y, Qian Y, Shao C, Lu J, Bian Y, Zheng J. Tumor Budding Score Is a Strong and Independent Prognostic Factor in Patients With Pancreatic Ductal Adenocarcinoma: An Evaluation of Whole Slide Pathology Images of Large Sections. Front Oncol 2021;11:740212. [DOI: 10.3389/fonc.2021.740212] [Reference Citation Analysis]
20 Zare SY, Ciscato A, Fadare O. Tumor Budding Activity Is an Independent Prognostic Factor in Squamous Cell Carcinoma of the Vulva. Hum Pathol 2022:S0046-8177(22)00123-X. [PMID: 35594936 DOI: 10.1016/j.humpath.2022.05.009] [Reference Citation Analysis]
21 Chong GO, Park SH, Park NJ, Bae BK, Lee YH, Jeong SY, Kim JC, Park JY, Ando Y, Han HS. Predicting Tumor Budding Status in Cervical Cancer Using MRI Radiomics: Linking Imaging Biomarkers to Histologic Characteristics. Cancers (Basel) 2021;13:5140. [PMID: 34680289 DOI: 10.3390/cancers13205140] [Reference Citation Analysis]
22 Dinneen K, Baird AM, Ryan C, Sheils O. The Role of Cancer Stem Cells in Drug Resistance in Gastroesophageal Junction Adenocarcinoma. Front Mol Biosci 2021;8:600373. [PMID: 33628765 DOI: 10.3389/fmolb.2021.600373] [Reference Citation Analysis]
23 Chen K, Wang H, Collins G, Hollands E, Law IYJ, Toh JWT. Current Perspectives on the Importance of Pathological Features in Prognostication and Guidance of Adjuvant Chemotherapy in Colon Cancer. Current Oncology 2022;29:1370-89. [DOI: 10.3390/curroncol29030116] [Reference Citation Analysis]
24 Gorchs L, Kaipe H. Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines. Cancers (Basel) 2021;13:2995. [PMID: 34203869 DOI: 10.3390/cancers13122995] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Basile D, Broudin C, Emile J, Falcoz A, Pagès F, Mineur L, Bennouna J, Louvet C, Artru P, Fratte S, Ghiringhelli F, André T, Derangère V, Vernerey D, Taieb J, Svrcek M. Tumor budding is an independent prognostic factor in stage III colon cancer patients: A post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR). Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2022.03.002] [Reference Citation Analysis]
26 Chen C, Wang J, Chen Y, Yang T. Exploration of the niche effect on tumor satellite budding of head and neck cancer with biomimicking modeling. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121471] [Reference Citation Analysis]
27 Sakaguchi T, Satoi S, Hashimoto D, Yamamoto T, Yamaki S, Hirooka S, Ishida M, Ikeura T, Inoue K, Naganuma M, Ishikawa H, Sekimoto M. High tumor budding predicts a poor prognosis in resected duodenal adenocarcinoma. Surg Today 2022. [PMID: 34988677 DOI: 10.1007/s00595-021-02433-z] [Reference Citation Analysis]
28 Yim K, Jang WM, Lee SH. Modified Tumor Budding as a Better Predictor of Lymph Node Metastasis in Early Gastric Cancer: Possible Real-World Applications. Cancers (Basel) 2021;13:3405. [PMID: 34298621 DOI: 10.3390/cancers13143405] [Reference Citation Analysis]
29 Noble R, Burri D, Le Sueur C, Lemant J, Viossat Y, Kather JN, Beerenwinkel N. Spatial structure governs the mode of tumour evolution. Nat Ecol Evol 2021. [PMID: 34949822 DOI: 10.1038/s41559-021-01615-9] [Reference Citation Analysis]
30 De Angelis ML, Francescangeli F, Zeuner A, Baiocchi M. Colorectal Cancer Stem Cells: An Overview of Evolving Methods and Concepts. Cancers (Basel) 2021;13:5910. [PMID: 34885020 DOI: 10.3390/cancers13235910] [Reference Citation Analysis]
31 Sadozai H, Acharjee A, Gruber T, Gloor B, Karamitopoulou E. Pancreatic Cancers with High Grade Tumor Budding Exhibit Hallmarks of Diminished Anti-Tumor Immunity. Cancers (Basel) 2021;13:1090. [PMID: 33806316 DOI: 10.3390/cancers13051090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Jechorek D, Haeusler-Pliske I, Meyer F, Roessner A. Diagnostic value of syndecan-4 protein expression in colorectal cancer. Pathol Res Pract 2021;222:153431. [PMID: 34029877 DOI: 10.1016/j.prp.2021.153431] [Reference Citation Analysis]
33 Tang L, He S, Yin Y, Li J, Xiao Q, Wang R, Gao L, Wang W. Combining nanotechnology with the multifunctional roles of neutrophils against cancer and inflammatory disease. Nanoscale 2022. [PMID: 35079756 DOI: 10.1039/d1nr07725b] [Reference Citation Analysis]
34 Naydenov NG, Lechuga S, Huang EH, Ivanov AI. Myosin Motors: Novel Regulators and Therapeutic Targets in Colorectal Cancer. Cancers (Basel) 2021;13:741. [PMID: 33670106 DOI: 10.3390/cancers13040741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Huang T, Bao H, Meng YH, Zhu JL, Chu XD, Chu XL, Pan JH. Tumour budding is a novel marker in breast cancer: the clinical application and future prospects. Ann Med 2022;54:1303-12. [PMID: 35535687 DOI: 10.1080/07853890.2022.2070272] [Reference Citation Analysis]
36 Arai K, Iwasaki T, Ishimatsu H, Tsuchiya C, Kubota A, Sonoda A, Ohata K. A Case of Colonic Micropapillary Carcinoma with a High Frequency of Apoptosis. J Gastrointest Cancer 2021. [PMID: 34302254 DOI: 10.1007/s12029-021-00674-2] [Reference Citation Analysis]
37 Ascenção K, Szabo C. Emerging roles of cystathionine β-synthase in various forms of cancer. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102331] [Reference Citation Analysis]
38 Loughrey MB, Fisher NC, McCooey AJ, Dunne PD. Comment on "Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes". Br J Cancer 2021;124:1175-6. [PMID: 33311590 DOI: 10.1038/s41416-020-01213-9] [Reference Citation Analysis]
39 Hatthakarnkul P, Quinn JA, Ammar A, Lynch G, Van Wyk H, McMillan DC, Thuwajit C, Edwards J. Molecular mechanisms of tumour budding and its association with microenvironment in colorectal cancer. Clin Sci (Lond) 2022;136:521-35. [PMID: 35445707 DOI: 10.1042/CS20210886] [Reference Citation Analysis]
40 Li M, Xiao Q, Venkatachalam N, Hofheinz R, Veldwijk MR, Herskind C, Ebert MP, Zhan T. Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models. Ther Adv Med Oncol 2022;14:175883592210779. [DOI: 10.1177/17588359221077972] [Reference Citation Analysis]
41 Feng C, Wang X, Tao Y, Xie Y, Lai Z, Li Z, Hu J, Tang S, Pan L, He L, Wang Q, Li T, Mo Z. Single-Cell Proteomic Analysis Dissects the Complexity of Tumor Microenvironment in Muscle Invasive Bladder Cancer. Cancers (Basel) 2021;13:5440. [PMID: 34771607 DOI: 10.3390/cancers13215440] [Reference Citation Analysis]
42 Mozarowski P, Rasaiah B, Reed M, Lewis A, Walde N, Voutsadakis IA. Prognostic Role of Tumor Budding in Breast Cancer Patients Receiving Neo-Adjuvant Therapy. J Clin Med 2021;10:827. [PMID: 33670512 DOI: 10.3390/jcm10040827] [Reference Citation Analysis]